Hospice News June 29, 2022
Jim Parker

Congressional legislators are casting doubts on regulatory oversight of Medicare Advantage plans over concerns about spending, claims denials, and end-of-life care.

Several lawmakers expressed these reservations during a House Energy and Commerce Committee’s Oversight and Investigation subcommittee hearing that focused on the Medicare Advantage program.

“Improper claim denials and increased use of prior authorizations are preventing beneficiaries from receiving the care they need,” Energy and Commerce Chairman Frank Pallone, Jr. (D-N.J.) said during the hearing. “While there are many plans that appear to be acting responsibly, some are not, and these bad actors are costing taxpayers money and, more importantly, jeopardizing the health of seniors.”

Officials from several federal agencies testified, including the U.S. Department of Health & Human Services...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: CMS, Congress / White House, Govt Agencies, Insurance, Medicare Advantage, OIG, Survey / Study, Trends
‘Long-Term Harm’: Former CMS Chief Warns HHS Cuts Will Impact Nursing Home Surveys, MA Oversight
Senate report scrutinizes Medicare Advantage marketing spend, broker practices
Nursing Home Relief: Bipartisan Bill Aims to Reform Prior Auth Among Medicare Advantage Plans
Risk Adjustment Reform: Navigating Ideas And Tradeoffs (Part 2)
Provider-sponsored Medicare Advantage plan enrollment shrinks

Share This Article